Heron Bay Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Heron Bay Capital Management's NVS Position: Q4 2023 in Review
Heron Bay Capital Management sold out of Novartis (NVS) in Q4 2023, closing a stake of 2,225 shares — an estimated $227K sold.
Heron Bay Capital Management first reported a position in NVS in Q2 2023 and held it in 2 quarters. The position peaked at $227K in Q3 2023. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.
- Heron Bay Capital Management reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
- Heron Bay Capital Management sold 2,225 Novartis shares in Q4 2023, an estimated $227K.
- Heron Bay Capital Management first reported a position in Novartis in Q2 2023 and held it in 2 quarters.
- Heron Bay Capital Management's Novartis position peaked at $227K in Q3 2023.
- 1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.
Based on Heron Bay Capital Management's 13F filing for Q4 2023, filed 12 Jan 2024.